Cited by 36Cardiovascular Syncope and Autonomic DisordersAcute Myocardial Infarction ResearchHeart Failure Treatment and Management

Prognostic value of cardiac biomarkers in the risk stratification of syncope: a systematic review

Thiruganasambandamoorthy, Venkatesh, Ramaekers, Rosa, Rahman, Mohammed Omair, Stiell, Ian Gilmour, Sikora, Lindsey, Kelly, Sarah-Louise, Christ, Michael, Claret, Pierre-Geraud +1 more·2015·Internal and Emergency Medicine

Abstract

The role of cardiac biomarkers in risk stratification of syncope is unclear. We undertook a systematic review to assess their predictive value for short-term major adverse cardiovascular events (MACE). We conducted a systematic review using MEDLINE, EMBASE, DARE and Cochrane databases from inception to July 2014. We included studies involving adult syncope patients that evaluated cardiac biomarker levels for risk stratification during acute management and excluded case reports, reviews and studies involving children. Primary outcome (MACE) included death, cardiopulmonary resuscitation, myocardial infarction (MI), structural heart disease, pulmonary embolism, significant hemorrhage or cardiac procedural interventions. Secondary outcome analysis assessed for prediction of MI, cardiac syncope and death. Two reviewers extracted patient-level data based on the cut-off reported. Pooled sensitivities and specificities were calculated using patient-level data. A total of 1862 articles were identified, and 11 studies with 4246 patients were included. Studies evaluated 3 biomarkers: contemporary troponin (2693 patients), natriuretic peptides (1353 patients) and high-sensitive troponin (819 patients). The pooled sensitivities and specificities for MACE were: contemporary troponin 0.29 (95 % CI 0.24, 0.34) and 0.88 (95 % CI 0.86, 0.89); natriuretic peptides 0.77 (95 % CI 0.69, 0.85) and 0.73 (95 % CI 0.70, 0.76); high-sensitive troponin 0.74 (95 % CI 0.65, 0.83) and 0.65 (95 % CI 0.62, 0.69), respectively. Natriuretic peptides and high-sensitive troponin showed good diagnostic characteristics for both primary and secondary outcomes. Natriuretic peptides and high-sensitive troponin might be useful in risk stratification.

Integrity signals

Registry

Crossref · 10.1007/s11739-015-1318-1

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Established cardiac biomarkers such as troponin and B-type natriuretic peptide have been used to distinguish cardiac from non-cardiac syncope and identify structural heart disease.

    “Established cardiac biomarkers such as troponin and B-type natriuretic peptide have been used to distinguish cardiac from non-cardiac syncope and identify structural heart disease. 223-225”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Thiruganasambandamoorthy, V., Ramaekers, R., Rahman, M. O., Stiell, I. G., Sikora, L., Kelly, S.-L., Christ, M., Claret, P.-G., & Reed, M. J.
Affiliations
  • University of Ottawa (CA)
  • Edinburgh Royal Infirmary (GB)
  • Nuremberg Hospital (DE)
Corresponding author
Thiruganasambandamoorthy, Venkatesh
Venue
Internal and Emergency Medicine
Published
2015-10-23
Volume
10
Issue
8
Pages
1003-1014
ISSN
  • 1828-0447 (ISSN-L)
  • 1970-9366
OpenAlex
W2172795178
Cited by
36
References
30
Citations by year
2025: 1 · 2024: 2 · 2023: 4 · 2022: 2 · 2021: 2 · 2020: 7 · 2019: 5 · 2018: 4 · 2017: 8 · 2016: 1
FWCI
0.83
Type
journal article
Language
en
Open access
closed
Locations
  • Internal and Emergency Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Funders
Department of Emergency Medicine, University of Ottawa
Topics
  • Health Sciences › Medicine › Surgery › Cardiovascular Syncope and Autonomic Disorders
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Keywords
syncope, cardiac biomarkers, risk stratification, major adverse cardiovascular events, high-sensitivity troponin, natriuretic peptides, myocardial infarction, cardiac syncope, prognostic value, diagnostic accuracy
MeSH terms
Humans, Myocardial Infarction, Prognosis, Syncope, Troponin, Biomarkers, Cardiopulmonary Resuscitation, Risk Assessment, Natriuretic Peptide, Brain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review